SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS
· Real-Time Price · USD
1.77
-0.05 (-2.75%)
At close: Jun 26, 2025, 3:59 PM
1.78
0.56%
After-hours: Jun 26, 2025, 04:00 PM EDT
SAB Biotherapeutics Revenue
SAB Biotherapeutics reported an annual revenue of $1.32M, reflecting a -40.94% growth. For the quarter ending March 31, 2025, SAB Biotherapeutics generated $0 in revenue.
Revenue (ttm)
$1.32M
Revenue Growth
-40.94%
Price / Sales Ratio
26.54
Revenue / Employee
$20.98K
Employees
63
Market Cap
16.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|